Current report
Open the filing on sec.gov
NexGel, Inc (NXGL)
Nasdaq: NXGL · Surgical & Medical Instruments & Apparatus · Langhorne, PA · filing with the SEC since 2009
The companyfiscal 2025, as filed
Revenue$11.4M+31.5%
Net income-$3.0M+8.6%
Earnings per share$-0.38+24.0%
Operating cash flow-$1.3M+66.1%
Cashn/a
Debt$588,000-14.2%
Shareholders’ equity$4.5M-22.5%
Shares, diluted7,854,288+20.6%
Return on equity-67.3%
The recordfrom its filings
Filings in 202647
Newest filingNov 12 · 8-K
Annual reportMar 31, 2026
Quarterly reportAug 17, 2026
Next report due10-Q by Nov 14
Insider sales, 12 months$100,000
Insider buys, 12 months$0.00
Patents grantedn/a
Filer category<br>Emerging growth company
Trailing twelve months to Jun 2026Revenue $12.1MNet income -$6.2MCash from operations -$3.2Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Current report
Open the filing on sec.gov
Notice of intended sale
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Proxy statement
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Listing registration
Open the filing on sec.gov
Results released
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.